Did we buy REGN at $30 $70?
ISIS has over 30 drugs in development. They also are selling cholesterol drug, revenue over $240M. It is not speculative like ESPR and many other biotech stocks with $0 revenues.
ISIS also has partnership with big names like GSK CELG AMGN..they get tons of funding from them.
Companies with one drug and has some progress, good news and stocks ran up to the roof.
Look at PLTA yesterday. The CEO said phase1 with potential. Great but only phase1.
ESPR good news on phase2, phase3 still unknown when and also approval of phase3. We are talking about 2 3 years away. Good cholesterol drug? So between now and when phase3 completes,no one has better drugs? We need to look at the whole picture.
So many other examples ONCE ANAC CLDN RCPT....look at the fundamental carefully before we invest or trade. I am an investor, trading here and there. Own quite a number of biotech stocks when they were much lower..AMGN CELG AGN, etc
Here is the BIG potential for ISIS. 31 products in pipe line. Who has 31 of them? ONE TWO products and people see huge potential. How about 31 or 33!
Big companies are investing in ISIS. They will acquire ISIS. Look at PCYC SLXP, AGN, etc
ISIS has much smaller market caps and better potential then many companies in this space.
Cramer has very short term impact because traders love to use the opportunity to short or buy. Newbies scared because they lack of ISIS business.
Understand the potential and keep adding shares. This is the new REGN. Cramer even said that many times even when stock was 70 75.
Please google Cramer' s record. There are sites out there do this. They measure % gains/losses after his recommendations and # of days that took for stocks to reverse. Amazing, we do the opposite on panic buying/ selling and can make great money swing trading. I learn a lot from Cramer but I do not follow him blindly. He introduced me to stocks
ISIS is a great investment, add slowly this baby REGN and will be rewarded.
turned to profit EPS. 25c, estimate 9c
also beat rev. beat over $2M
so beat top and bottom lines. for a biotech with growth 100.5% YoY and tturned to profit in a big way. ISIS will be $100 and higher overtime. CEO was on Cramer show. Cramer said ISIS is the new REGN. REGN was $25 in 2009